[go: up one dir, main page]

NO170194C - Fremgangsmaate for fremstilling av fysiologisk aktive saarhelingsstoffer - Google Patents

Fremgangsmaate for fremstilling av fysiologisk aktive saarhelingsstoffer

Info

Publication number
NO170194C
NO170194C NO862964A NO862964A NO170194C NO 170194 C NO170194 C NO 170194C NO 862964 A NO862964 A NO 862964A NO 862964 A NO862964 A NO 862964A NO 170194 C NO170194 C NO 170194C
Authority
NO
Norway
Prior art keywords
procedure
preparation
physiologically active
active health
cells
Prior art date
Application number
NO862964A
Other languages
English (en)
Norwegian (no)
Other versions
NO862964L (no
NO862964D0 (no
NO170194B (no
Inventor
David R Knighton
Original Assignee
Curatech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curatech Inc filed Critical Curatech Inc
Publication of NO862964L publication Critical patent/NO862964L/no
Publication of NO862964D0 publication Critical patent/NO862964D0/no
Publication of NO170194B publication Critical patent/NO170194B/no
Publication of NO170194C publication Critical patent/NO170194C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
NO862964A 1984-11-29 1986-07-23 Fremgangsmaate for fremstilling av fysiologisk aktive saarhelingsstoffer NO170194C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67647184A 1984-11-29 1984-11-29
US78620685A 1985-10-18 1985-10-18
PCT/US1985/002205 WO1986003122A1 (en) 1984-11-29 1985-11-08 Wound healing agents

Publications (4)

Publication Number Publication Date
NO862964L NO862964L (no) 1986-07-23
NO862964D0 NO862964D0 (no) 1986-07-23
NO170194B NO170194B (no) 1992-06-15
NO170194C true NO170194C (no) 1992-09-23

Family

ID=27101561

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862964A NO170194C (no) 1984-11-29 1986-07-23 Fremgangsmaate for fremstilling av fysiologisk aktive saarhelingsstoffer

Country Status (16)

Country Link
EP (2) EP0383363A3 (da)
AT (1) ATE78167T1 (da)
AU (1) AU596954B2 (da)
CA (1) CA1261259A (da)
CH (1) CH673774A5 (da)
DE (2) DE3590594T1 (da)
DK (1) DK165169C (da)
FI (1) FI85219C (da)
GB (1) GB2248777B (da)
HU (1) HUT42329A (da)
IE (1) IE57894B1 (da)
IL (1) IL77096A (da)
NL (1) NL8520384A (da)
NO (1) NO170194C (da)
SE (1) SE8603228D0 (da)
WO (1) WO1986003122A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487116B1 (en) * 1984-10-12 1999-12-29 ZymoGenetics, Inc. Biologically active PDGF analogs in eucaryotic cells
US5187263A (en) * 1984-10-12 1993-02-16 Zymogenetics, Inc. Expression of biologically active PDGE analogs in eucaryotic cells
US5498600A (en) * 1984-10-12 1996-03-12 Zymogenetics, Inc. Biologically active mosaic proteins
US5045633A (en) * 1985-02-25 1991-09-03 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
IL84911A (en) * 1987-12-22 1993-04-04 Yissum Res Dev Co Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
US5814602A (en) * 1988-03-17 1998-09-29 Novo Nordisk A/S Heparin-binding proteins
US4900541A (en) * 1988-05-06 1990-02-13 Govier William C Sunscreen composition
IT1217938B (it) * 1988-06-28 1990-03-30 Girolamo Sirchia Procedimento per la preparazione e la conservazione di concentrati eritrocitari e piastrinici
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
US5599558A (en) * 1989-09-15 1997-02-04 Curative Technologies, Inc. Selecting amounts of platelet releasate for efficacious treatment of tissue
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
JP3604688B2 (ja) * 1990-11-27 2004-12-22 ジ・アメリカン・ナショナル・レッド・クロス 加速された傷の治癒を促進する組織シーラントおよび成長因子含有組成物
US7229959B1 (en) 1990-11-27 2007-06-12 The American National Red Cross Supplemented fibrin matrix delivery systems
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US5171579A (en) * 1991-10-11 1992-12-15 Genetics Institute, Inc. Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
IL105529A0 (en) * 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins
FR2691911B1 (fr) * 1992-06-05 1994-11-25 Delmas Olivier Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu.
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
EP0637450A3 (en) * 1993-08-04 1995-04-05 Collagen Corp Method and composition for resuscitation of hereditary tissue.
WO1995015763A1 (en) * 1993-12-08 1995-06-15 Universite De Montreal Process for the preparation of serum and platelet growth factors extract
US5733545A (en) * 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
JPH11505713A (ja) * 1995-05-24 1999-05-25 セルファクターズ ピーエルシー 細胞分化剤
WO1996039208A1 (en) 1995-06-06 1996-12-12 Quantic Biomedical Partners Device and method for concentrating plasma
US5834418A (en) * 1996-03-20 1998-11-10 Theratechnologies, Inc. Process for the preparation of platelet growth factors extract
US6102926A (en) 1996-12-02 2000-08-15 Angiotrax, Inc. Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use
US6120520A (en) 1997-05-27 2000-09-19 Angiotrax, Inc. Apparatus and methods for stimulating revascularization and/or tissue growth
US6051008A (en) 1996-12-02 2000-04-18 Angiotrax, Inc. Apparatus having stabilization members for percutaneously performing surgery and methods of use
US6117444A (en) * 1997-04-10 2000-09-12 Brigham & Women's Hospital Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6524568B2 (en) 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
NZ509122A (en) * 1998-06-22 2003-09-26 Cytomedix Inc Wound healant comprising activated growth from platelets and ascorbic acid
US6432119B1 (en) 1999-03-17 2002-08-13 Angiotrax, Inc. Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials
US8529956B2 (en) 2002-03-18 2013-09-10 Carnell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US8293530B2 (en) 2006-10-17 2012-10-23 Carnegie Mellon University Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
WO2003094937A1 (en) 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
JP4777650B2 (ja) 2002-09-10 2011-09-21 アメリカン ナショナル レッド クロス 止血用包帯
WO2005105121A1 (en) * 2004-05-05 2005-11-10 Synthes Gmbh Use of platelets or platelet rich plasma (prp)
US8529961B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US20090075891A1 (en) 2007-08-06 2009-03-19 Macphee Martin Methods and dressings for sealing internal injuries
WO2020112963A1 (en) 2018-11-30 2020-06-04 Cellphire, Inc. Platelets as delivery agents
EP3887402A4 (en) 2018-11-30 2022-10-26 Cellphire, Inc. PLATELETS AS RELEASING AGENT
BR112021021984A2 (pt) 2019-05-03 2022-03-03 Cellphire Inc Materiais e métodos para produzir produtos de sangue
JP2022545390A (ja) 2019-08-16 2022-10-27 セルフィアー インコーポレイテッド 抗血小板剤拮抗剤としてのトロンボソーム
CA3170196A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Anti-fibrinolytic loaded platelets

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195061A (en) * 1966-05-27 1970-06-17 Fmc Corp Coated Structures and Methods of Forming Them.
FR2472385A1 (fr) * 1979-12-27 1981-07-03 Sederma Sa Nouveaux extraits biologiques utilisables en cosmetologie, et procedes d'obtention de ces extraits
FR2533438B2 (fr) * 1979-12-27 1986-03-07 Sederma Sarl Utilisation en cosmetologie des facteurs de croissance et d'extraits biologiques contenant ceux-ci
DE3110560A1 (de) * 1981-03-18 1982-10-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor
US4444760A (en) * 1983-06-17 1984-04-24 Merck & Co., Inc. Purification and characterization of a protein fibroblast growth factor

Also Published As

Publication number Publication date
AU5094985A (en) 1986-06-18
DE3590594T1 (da) 1987-01-29
FI85219B (fi) 1991-12-13
SE8603228L (sv) 1986-07-25
IE57894B1 (en) 1993-05-05
AU596954B2 (en) 1990-05-24
GB8617658D0 (en) 1986-08-28
IE852810L (en) 1986-05-29
CH673774A5 (da) 1990-04-12
FI863087A0 (fi) 1986-07-28
EP0202298B1 (en) 1992-07-15
NO862964L (no) 1986-07-23
GB2248777A (en) 1992-04-22
IL77096A (en) 1993-01-31
WO1986003122A1 (en) 1986-06-05
NL8520384A (nl) 1986-10-01
DK165169C (da) 1993-03-01
EP0383363A3 (en) 1990-10-03
CA1261259A (en) 1989-09-26
DK357386A (da) 1986-07-28
DE3586355D1 (de) 1992-08-20
DE3586355T2 (de) 1993-01-14
EP0383363A2 (en) 1990-08-22
SE8603228D0 (sv) 1986-07-25
FI85219C (fi) 1992-03-25
NO862964D0 (no) 1986-07-23
NO170194B (no) 1992-06-15
EP0202298A4 (en) 1988-07-04
DK357386D0 (da) 1986-07-28
ATE78167T1 (de) 1992-08-15
DK165169B (da) 1992-10-19
GB2248777B (en) 1993-06-30
FI863087A (fi) 1986-07-28
HUT42329A (en) 1987-07-28
EP0202298A1 (en) 1986-11-26

Similar Documents

Publication Publication Date Title
NO170194C (no) Fremgangsmaate for fremstilling av fysiologisk aktive saarhelingsstoffer
DE69617723D1 (de) Wachsumsfaktoren enthaltende gelformulierungen
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ES2116986T3 (es) Composiciones de metal-peptidos y metodos cosmeticos para estimular el crecimiento del cabello.
ATE227587T1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
DK360489A (da) Produkter indeholdende mikro- eller nanopartikler samt fremgangsmaade til deres fremstilling
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
DE69332350D1 (de) Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen
DE69007964D1 (de) Verwendung von Thrombospondin zur Beschleunigung der Wundheilung.
ATE337333T1 (de) Ophthalmische arzneimittelzusammenstellung
ATE43244T1 (de) Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.
ATE113849T1 (de) Verwendung von polysacchariden in zubereitungen zur wundbehandlung.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
FR2657258B1 (da)
ATE46083T1 (de) Arzneimittel zur topischen anwendung.
ATE97574T1 (de) Arzneimittelzusammensetzung, enthaltend deoxyribonukleoside fuer heilung von wunden.